CoChat
Sign Up
Cited by 204

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis

Kamata, Masahiro, Tada, Yayoi·2022·Frontiers in Immunology
DOI 10.3389/fimmu.2022.941071PMC PMC9274091
Open this paper in CoChat — free account

Abstract

Psoriasis is a chronic inflammatory skin disease characterized by scaly indurated erythema. This disease impairs patients’ quality of life enormously. Pathological findings demonstrate proliferation and abnormal differentiation of keratinocytes and massive infiltration of inflammatory immune cells. The pathogenesis of psoriasis is complicated. Among immune cells, dendritic cells play a pivotal role in the development of psoriasis in both the initiation and the maintenance phases. In addition, it has been indicated that macrophages contribute to the pathogenesis of psoriasis especially in the initiation phase, although studies on macrophages are limited. In this article, we review the roles of dendritic cells and macrophages in the pathogenesis of psoriasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2022.941071

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Overview of the current understanding of the pathogenesis of psoriasis and the roles of dendritic cells and macrophages. DC, dendritic cells; pDC, plasmacytoid DC; iDC, inflammatory DC.
Figure 1 Overview of the current understanding of the pathogenesis of psoriasis and the roles of dendritic cells and macrophages. DC, dendritic cells; pDC, plasmacytoid DC; iDC, inflammatory DC.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 125

  1. Wang, 2020, Dendritic Cells: The Driver of Psoriasis, J Dermatol, 47, 10.1111/1346-8138.15184 · DOI
  2. Lynde, 2014, Interleukin 17A: Toward a New Understanding of Psoriasis Pathogenesis, J Am Acad Dermatol, 71, 10.1016/j.jaad.2013.12.036 · DOI
  3. Ogawa, 2018, Pathogenesis of Psoriasis and Development of Treatment, J Dermatol, 45, 10.1111/1346-8138.14139 · DOI
  4. Kamata, 2020, Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review, Int J Mol Sci, 21, 1690, 10.3390/ijms21051690 · DOI
  5. Boltjes, 2014, Human Dendritic Cell Functional Specialization in Steady-State and Inflammation, Front Immunol, 5, 10.3389/fimmu.2014.00131 · DOI
  6. Dzionek, 2000, BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood, J Immunol, 165, 10.4049/jimmunol.165.11.6037 · DOI
  7. Ziegler-Heitbrock, 2010, Nomenclature of Monocytes and Dendritic Cells in Blood, Blood, 116, 10.1182/blood-2010-02-258558 · DOI
  8. Robbins, 2008, Novel Insights Into the Relationships Between Dendritic Cell Subsets in Human and Mouse Revealed by Genome-Wide Expression Profiling, Genome Biol, 9, R17, 10.1186/gb-2008-9-1-r17 · DOI
  9. Schlitzer, 2013, IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses, Immunity, 38, 10.1016/j.immuni.2013.04.011 · DOI
  10. Haniffa, 2012, Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells With Functional Homology to Mouse CD103+ Nonlymphoid Dendritic Cells, Immunity, 37, 60, 10.1016/j.immuni.2012.04.012 · DOI
  11. Klechevsky, 2008, Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells, Immunity, 29, 497, 10.1016/j.immuni.2008.07.013 · DOI
  12. Chu, 2011, Harnessing Dendritic Cells in Inflammatory Skin Diseases, Semin Immunol, 23, 28, 10.1016/j.smim.2011.01.006 · DOI
  13. Suzuki, 2018, The Vitamin D3 Analogue Calcipotriol Suppresses CpG-Activated TLR9-MyD88 Signalling in Murine Plasmacytoid Dendritic Cells, Clin Exp Dermatol, 43, 10.1111/ced.13397 · DOI
  14. Menezes, 2016, The Heterogeneity of Ly6C(hi) Monocytes Controls Their Differentiation Into iNOS(+) Macrophages or Monocyte-Derived Dendritic Cells, Immunity, 45, 10.1016/j.immuni.2016.12.001 · DOI
  15. Provoost, 2012, Monocyte-Derived Dendritic Cell Recruitment and Allergic T(H)2 Responses After Exposure to Diesel Particles are CCR2 Dependent, J Allergy Clin Immunol, 129, 10.1016/j.jaci.2011.07.051 · DOI
  16. Nestle, 2005, Plasmacytoid Predendritic Cells Initiate Psoriasis Through Interferon-Alpha Production, J Exp Med, 202, 10.1084/jem.20050500 · DOI
  17. Wollenberg, 2002, Plasmacytoid Dendritic Cells: A New Cutaneous Dendritic Cell Subset With Distinct Role in Inflammatory Skin Diseases, J Invest Dermatol, 119, 10.1046/j.1523-1747.2002.19515.x · DOI
  18. Tohyama, 2012, IFN-α Enhances IL-22 Receptor Expression in Keratinocytes: A Possible Role in the Development of Psoriasis, J Invest Dermatol, 132, 10.1038/jid.2011.468 · DOI
  19. Zheng, 2019, C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis, Front Immunol, 10, 10.3389/fimmu.2019.01866 · DOI
  20. Takagi, 2016, Plasmacytoid Dendritic Cells Orchestrate TLR7-Mediated Innate and Adaptive Immunity for the Initiation of Autoimmune Inflammation, Sci Rep, 6, 10.1038/srep24477 · DOI
  21. Kopfnagel, 2018, RNase 7 Strongly Promotes TLR9-Mediated DNA Sensing by Human Plasmacytoid Dendritic Cells, J Invest Dermatol, 138, 10.1016/j.jid.2017.09.052 · DOI
  22. Lande, 2015, Cationic Antimicrobial Peptides in Psoriatic Skin Cooperate to Break Innate Tolerance to Self-DNA, Eur J Immunol, 45, 10.1002/eji.201344277 · DOI
  23. Morizane, 2012, Cathelicidin Antimicrobial Peptide LL-37 in Psoriasis Enables Keratinocyte Reactivity Against TLR9 Ligands, J Invest Dermatol, 132, 10.1038/jid.2011.259 · DOI
  24. Ganguly, 2009, Self-RNA-Antimicrobial Peptide Complexes Activate Human Dendritic Cells Through TLR7 and TLR8, J Exp Med, 206, 10.1084/jem.20090480 · DOI
  25. Skrzeczynska-Moncznik, 2013, DNA Structures Decorated With Cathepsin G/secretory Leukocyte Proteinase Inhibitor Stimulate IFNI Production by Plasmacytoid Dendritic Cells, Am J Clin Exp Immunol, 2
  26. Lande, 2010, Plasmacytoid Dendritic Cells: Key Players in the Initiation and Regulation of Immune Responses, Ann N Y Acad Sci, 1183, 89, 10.1111/j.1749-6632.2009.05152.x · DOI
  27. Santini, 2000, Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity In Vitro and in Hu-PBL-SCID Mice, J Exp Med, 191, 10.1084/jem.191.10.1777 · DOI
  28. Ueyama, 2014, Mechanism of Pathogenesis of Imiquimod-Induced Skin Inflammation in the Mouse: A Role for Interferon-Alpha in Dendritic Cell Activation by Imiquimod, J Dermatol, 41, 10.1111/1346-8138.12367 · DOI
  29. Bissonnette, 2010, A Randomized, Double-Blind, Placebo-Controlled, Phase I Study of MEDI-545, an Anti-Interferon-Alfa Monoclonal Antibody, in Subjects With Chronic Psoriasis, J Am Acad Dermatol, 62, 10.1016/j.jaad.2009.05.042 · DOI
  30. Zaba, 2007, Amelioration of Epidermal Hyperplasia by TNF Inhibition is Associated With Reduced Th17 Responses, J Exp Med, 204, 10.1084/jem.20071094 · DOI
  31. Austin, 1999, The Majority of Epidermal T Cells in Psoriasis Vulgaris Lesions Can Produce Type 1 Cytokines, Interferon-Gamma, Interleukin-2, and Tumor Necrosis Factor-Alpha, Defining TC1 (Cytotoxic T Lymphocyte) and TH1 Effector Populations: A Type 1 Differentiation Bias Is Also Measured in Circulating Blood T Cells in Psoriatic Patients, J Invest Dermatol, 113, 10.1046/j.1523-1747.1999.00749.x · DOI
  32. Ferenczi, 2000, CD69, HLA-DR and the IL-2R Identify Persistently Activated T Cells in Psoriasis Vulgaris Lesional Skin: Blood and Skin Comparisons by Flow Cytometry, J Autoimmun, 14, 63, 10.1006/jaut.1999.0343 · DOI
  33. Nestle, 1994, Characterization of Dermal Dendritic Cells in Psoriasis. Autostimulation of T Lymphocytes and Induction of Th1 Type Cytokines, J Clin Invest, 94, 10.1172/jci117308 · DOI
  34. Zaba, 2009, Psoriasis is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells, J Invest Dermatol, 129, 79, 10.1038/jid.2008.194 · DOI
  35. Guttman-Yassky, 2008, Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis, J Immunol, 181, 10.4049/jimmunol.181.10.7420 · DOI
  36. Lee, 2004, Increased Expression of Interleukin 23 P19 and P40 in Lesional Skin of Patients With Psoriasis Vulgaris, J Exp Med, 199, 10.1084/jem.20030451 · DOI
  37. Piskin, 2006, In Vitro and in Situ Expression of IL-23 by Keratinocytes in Healthy Skin and Psoriasis Lesions: Enhanced Expression in Psoriatic Skin, J Immunol, 176, 10.4049/jimmunol.176.3.1908 · DOI
  38. Lowes, 2005, Increase in TNF-Alpha and Inducible Nitric Oxide Synthase-Expressing Dendritic Cells in Psoriasis and Reduction With Efalizumab (Anti-CD11a), Proc Natl Acad Sci U S A, 102, 10.1073/pnas.0509736102 · DOI
  39. Hänsel, 2011, Human Slan (6-Sulfo LacNAc) Dendritic Cells are Inflammatory Dermal Dendritic Cells in Psoriasis and Drive Strong TH17/TH1 T-Cell Responses, J Allergy Clin Immunol, 127, 10.1016/j.jaci.2010.12.009 · DOI
  40. Ahmad, 2019, Current Concepts on 6-Sulfo LacNAc Expressing Monocytes (slanMo), Front Immunol, 10, 10.3389/fimmu.2019.00948 · DOI
  41. Cros, 2010, Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors, Immunity, 33, 10.1016/j.immuni.2010.08.012 · DOI
  42. Lowes, 2008, Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells, J Invest Dermatol, 128, 10.1038/sj.jid.5701213 · DOI
  43. Wilson, 2007, Development, Cytokine Profile and Function of Human Interleukin 17-Producing Helper T Cells, Nat Immunol, 8, 10.1038/ni1497 · DOI · Paper page
  44. Baran, 2018, Phenotype, Function, and Mobilization of 6-Sulfo LacNAc-Expressing Monocytes in Atopic Dermatitis, Front Immunol, 9, 10.3389/fimmu.2018.01352 · DOI
  45. Kunze, 2017, Autocrine TNF-α and IL-1β Prime 6-Sulfo LacNAc(+) Dendritic Cells for High-Level Production of IL-23, Exp Dermatol, 26, 10.1111/exd.13134 · DOI
  46. Brunner, 2013, Infliximab Induces Downregulation of the IL-12/IL-23 Axis in 6-Sulfo-LacNac (Slan)+ Dendritic Cells and Macrophages, J Allergy Clin Immunol, 132, 1184, 10.1016/j.jaci.2013.05.036 · DOI
  47. Oehrl, 2017, Controlling the Pro-Inflammatory Function of 6-Sulfo LacNAc (Slan) Dendritic Cells With Dimethylfumarate, J Dermatol Sci, 87, 10.1016/j.jdermsci.2017.06.016 · DOI
  48. Dutertre, 2019, Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells, Immunity, 51, 573, 10.1016/j.immuni.2019.08.008 · DOI
  49. Nakamizo, 2021, Single-Cell Analysis of Human Skin Identifies CD14+ Type 3 Dendritic Cells Co-Producing IL1B and IL23A in Psoriasis, J Exp Med, 218, e20202345, 10.1084/jem.20202345 · DOI
  50. Liu, 2021, Distinct Human Langerhans Cell Subsets Orchestrate Reciprocal Functions and Require Different Developmental Regulation, Immunity, 54, 2305, 10.1016/j.immuni.2021.08.012 · DOI
  51. Merad, 2002, Langerhans Cells Renew in the Skin Throughout Life Under Steady-State Conditions, Nat Immunol, 3, 10.1038/ni852 · DOI
  52. Deckers, 2018, Langerhans Cells: Sensing the Environment in Health and Disease, Front Immunol, 9, 10.3389/fimmu.2018.00093 · DOI
  53. Otsuka, 2018, Uncovering the Mysteries of Langerhans Cells, Inflammatory Dendritic Epidermal Cells, and Monocyte-Derived Langerhans Cell-Like Cells in the Epidermis, Front Immunol, 9, 10.3389/fimmu.2018.01768 · DOI
  54. Ginhoux, 2006, Langerhans Cells Arise From Monocytes, In Vivo. Nat Immunol, 7, 10.1038/ni1307 · DOI
  55. Singh, 2016, Monocyte-Derived Inflammatory Langerhans Cells and Dermal Dendritic Cells Mediate Psoriasis-Like Inflammation, Nat Commun, 7, 10.1038/ncomms13581 · DOI
  56. Seré, 2012, Two Distinct Types of Langerhans Cells Populate the Skin During Steady State and Inflammation, Immunity, 37, 10.1016/j.immuni.2012.07.019 · DOI
  57. Lee, 2018, Resident and Monocyte-Derived Langerhans Cells Are Required for Imiquimod-Induced Psoriasis-Like Dermatitis Model, J Dermatol Sci, 91, 10.1016/j.jdermsci.2018.04.003 · DOI
  58. Fujita, 2011, Lesional Dendritic Cells in Patients With Chronic Atopic Dermatitis and Psoriasis Exhibit Parallel Ability to Activate T-Cell Subsets, J Allergy Clin Immunol, 128, 10.1016/j.jaci.2011.05.016 · DOI
  59. Terhorst, 2015, Dynamics and Transcriptomics of Skin Dendritic Cells and Macrophages in an Imiquimod-Induced, Biphasic Mouse Model of Psoriasis, J Immunol, 195, 10.4049/jimmunol.1500551 · DOI
  60. Bos, 1983, Immunocompetent Cells in Psoriasis. In Situ Immunophenotyping by Monoclonal Antibodies, Arch Dermatol Res, 275, 10.1007/bf00510050 · DOI
  61. Lisi, 1973, Investigation on Langerhans Cells in Pathological Human Epidermis, Acta Derm Venereol, 53, 10.2340/0001555553425428 · DOI
  62. Guttman-Yassky, 2007, Major Differences in Inflammatory Dendritic Cells and Their Products Distinguish Atopic Dermatitis From Psoriasis, J Allergy Clin Immunol, 119, 10.1016/j.jaci.2007.03.006 · DOI
  63. Martini, 2017, Dynamic Changes in Resident and Infiltrating Epidermal Dendritic Cells in Active and Resolved Psoriasis, J Invest Dermatol, 137, 10.1016/j.jid.2016.11.033 · DOI
  64. Wohn, 2013, Langerin(neg) Conventional Dendritic Cells Produce IL-23 to Drive Psoriatic Plaque Formation in Mice, Proc Natl Acad Sci U S A, 110, 10.1073/pnas.1307569110 · DOI
  65. Cumberbatch, 2006, Impaired Langerhans Cell Migration in Psoriasis, J Exp Med, 203, 10.1084/jem.20052367 · DOI
  66. Eaton, 2018, Impaired Langerhans Cell Migration in Psoriasis Is Due to an Altered Keratinocyte Phenotype Induced by Interleukin-17, Br J Dermatol, 178, 10.1111/bjd.16172 · DOI
  67. Glitzner, 2014, Specific Roles for Dendritic Cell Subsets During Initiation and Progression of Psoriasis, EMBO Mol Med, 6, 10.15252/emmm.201404114 · DOI
  68. Nakajima, 2019, Stat3 Activation in Epidermal Keratinocytes Induces Langerhans Cell Activation to Form an Essential Circuit for Psoriasis via IL-23 Production, J Dermatol Sci, 93, 82, 10.1016/j.jdermsci.2018.11.007 · DOI
  69. Zheng, 2018, P38α Signaling in Langerhans Cells Promotes the Development of IL-17-Producing T Cells and Psoriasiform Skin Inflammation, Sci Signal, 11, eaa01685, 10.1126/scisignal.aao1685 · DOI
  70. Yoshiki, 2014, IL-23 From Langerhans Cells Is Required for the Development of Imiquimod-Induced Psoriasis-Like Dermatitis by Induction of IL-17A-Producing γδ T Cells, J Invest Dermatol, 134, 10.1038/jid.2014.98 · DOI
  71. Xiao, 2017, Activation of Langerhans Cells Promotes the Inflammation in Imiquimod-Induced Psoriasis-Like Dermatitis, J Dermatol Sci, 85, 10.1016/j.jdermsci.2016.12.003 · DOI
  72. Boltjes, 2014, The Role of Kupffer Cells in Hepatitis B and Hepatitis C Virus Infections, J Hepatol, 61, 10.1016/j.jhep.2014.04.026 · DOI
  73. Schiwon, 2014, Crosstalk Between Sentinel and Helper Macrophages Permits Neutrophil Migration Into Infected Uroepithelium, Cell, 156, 10.1016/j.cell.2014.01.006 · DOI
  74. Guilliams, 2013, Alveolar Macrophages Develop From Fetal Monocytes That Differentiate Into Long-Lived Cells in the First Week of Life via GM-CSF, J Exp Med, 210, 10.1084/jem.20131199 · DOI
  75. Jenkins, 2011, Local Macrophage Proliferation, Rather Than Recruitment From the Blood, Is a Signature of TH2 Inflammation, Science, 332, 10.1126/science.1204351 · DOI
  76. Zigmond, 2013, Intestinal Macrophages: Well Educated Exceptions From the Rule, Trends Immunol, 34, 10.1016/j.it.2013.02.001 · DOI
  77. Lichtnekert, 2013, Changes in Macrophage Phenotype as the Immune Response Evolves, Curr Opin Pharmacol, 13, 10.1016/j.coph.2013.05.013 · DOI
  78. Atri, 2018, Role of Human Macrophage Polarization in Inflammation During Infectious Diseases, Int J Mol Sci, 19, 1801, 10.3390/ijms19061801 · DOI
  79. Kuraitis, 2022, Macrophages in Dermatology: Pathogenic Roles and Targeted Therapeutics, Arch Dermatol Res, 314, 10.1007/s00403-021-02207-0 · DOI
  80. Clark, 2006, Misbehaving Macrophages in the Pathogenesis of Psoriasis, J Clin Invest, 116, 10.1172/jci29441 · DOI
  81. Lorthois, 2017, Contribution of In Vivo and Organotypic 3d Models to Understanding the Role of Macrophages and Neutrophils in the Pathogenesis of Psoriasis, Mediators Inflammation, 2017, 10.1155/2017/7215072 · DOI
  82. Ward, 2011, Depletion of Antigen-Presenting Cells by Clodronate Liposomes Reverses the Psoriatic Skin Phenotype in KC-Tie2 Mice, Br J Dermatol, 164, 10.1111/j.1365-2133.2010.10129.x · DOI
  83. Nguyen, 2018, Up-Regulated Expression of CD86 on Circulating Intermediate Monocytes Correlated With Disease Severity in Psoriasis, J Dermatol Sci, 90, 10.1016/j.jdermsci.2018.01.005 · DOI · Paper page
  84. Golden, 2015, Chronic Psoriatic Skin Inflammation Leads to Increased Monocyte Adhesion and Aggregation, J Immunol, 195, 10.4049/jimmunol.1402307 · DOI
  85. Lin, 2018, Treatment With TNF-α Inhibitor Rectifies M1 Macrophage Polarization From Blood CD14+ Monocytes in Patients With Psoriasis Independent of STAT1 and IRF-1 Activation, J Dermatol Sci, 91, 10.1016/j.jdermsci.2018.05.009 · DOI
  86. Leite Dantas, 2016, Macrophage-Mediated Psoriasis Can be Suppressed by Regulatory T Lymphocytes, J Pathol, 240, 10.1002/path.4786 · DOI
  87. Kim, 2019, Decreased Expression of Response Gene to Complement 32 in Psoriasis and Its Association With Reduced M2 Macrophage Polarization, J Dermatol, 46, 10.1111/1346-8138.14733 · DOI
  88. Marble, 2007, Targeting TNFalpha Rapidly Reduces Density of Dendritic Cells and Macrophages in Psoriatic Plaques With Restoration of Epidermal Keratinocyte Differentiation, J Dermatol Sci, 48, 87, 10.1016/j.jdermsci.2007.06.006 · DOI
  89. Fuentes-Duculan, 2010, A Subpopulation of CD163-Positive Macrophages Is Classically Activated in Psoriasis, J Invest Dermatol, 130, 10.1038/jid.2010.165 · DOI
  90. Mahil, 2016, Update on Psoriasis Immunopathogenesis and Targeted Immunotherapy, Semin Immunopathol, 38, 11, 10.1007/s00281-015-0539-8 · DOI
  91. Yawalkar, 2009, Increased Expression of IL-12p70 and IL-23 by Multiple Dendritic Cell and Macrophage Subsets in Plaque Psoriasis, J Dermatol Sci, 54, 99, 10.1016/j.jdermsci.2009.01.003 · DOI
  92. Wang, 2019, Monocytes/Macrophages Play a Pathogenic Role in IL-23 Mediated Psoriasis-Like Skin Inflammation, Sci Rep, 9, 5310, 10.1038/s41598-019-41655-7 · DOI
  93. Hou, 2018, IL-23-Induced Macrophage Polarization and its Pathological Roles in Mice With Imiquimod-Induced Psoriasis, Protein Cell, 9, 10.1007/s13238-018-0505-z · DOI · Paper page
  94. Das, 2015, Monocyte and Macrophage Plasticity in Tissue Repair and Regeneration, Am J Pathol, 185, 10.1016/j.ajpath.2015.06.001 · DOI
  95. Gaire, 2020, Lysophosphatidic Acid Receptor 5 Contributes to Imiquimod-Induced Psoriasis-Like Lesions Through NLRP3 Inflammasome Activation in Macrophages, Cells, 9, 1753, 10.3390/cells9081753 · DOI
  96. Syed, 2020, Sphingosine Kinases are Involved in Macrophage NLRP3 Inflammasome Transcriptional Induction, Int J Mol Sci, 21, 4733, 10.3390/ijms21134733 · DOI
  97. Deng, 2019, Inhibition of NLRP3 Inflammasome-Mediated Pyroptosis in Macrophage by Cycloastragenol Contributes to Amelioration of Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice, Int Immunopharmacol, 74, 10.1016/j.intimp.2019.105682 · DOI
  98. Lu, 2018, Involvement of M1 Macrophage Polarization in Endosomal Toll-Like Receptors Activated Psoriatic Inflammation, Mediators Inflammation, 2018, 10.1155/2018/3523642 · DOI
  99. Miki, 2020, 4-1bbl Regulates the Polarization of Macrophages, and Inhibition of 4-1BBL Signaling Alleviates Imiquimod-Induced Psoriasis, J Immunol, 204, 10.4049/jimmunol.1900983 · DOI
  100. Tang, 2014, Response Gene to Complement 32 Protein Promotes Macrophage Phagocytosis via Activation of Protein Kinase C Pathway, J Biol Chem, 289, 10.1074/jbc.M114.566653 · DOI
  101. Wang, 2014, Interleukin-35 Induces Regulatory B Cells That Suppress Autoimmune Disease, Nat Med, 20, 10.1038/nm.3554 · DOI
  102. Zhang, 2016, IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis, J Immunol, 197, 10.4049/jimmunol.1600446 · DOI
  103. Yang, 2021, Hsa_circ_0004287 Inhibits Macrophage-Mediated Inflammation in an N(6)-Methyladenosine-Dependent Manner in Atopic Dermatitis and Psoriasis, J Allergy Clin Immunol, 149, 10.1016/j.jaci.2021.11.024 · DOI
  104. Schuster, 2020, S1PR4-Dependent CCL2 Production Promotes Macrophage Recruitment in a Murine Psoriasis Model, Eur J Immunol, 50, 10.1002/eji.201948349 · DOI
  105. Morimura, 2016, CX3CR1 Deficiency Attenuates Imiquimod-Induced Psoriasis-Like Skin Inflammation With Decreased M1 Macrophages, J Dermatol Sci, 82, 10.1016/j.jdermsci.2016.03.004 · DOI
  106. Vestergaard, 2004, Expression of CCR2 on Monocytes and Macrophages in Chronically Inflamed Skin in Atopic Dermatitis and Psoriasis, Acta Derm Venereol, 84, 10.1080/00015550410034444 · DOI
  107. Vanbervliet, 2002, Sequential Involvement of CCR2 and CCR6 Ligands for Immature Dendritic Cell Recruitment: Possible Role at Inflamed Epithelial Surfaces, Eur J Immunol, 32, 10.1002/1521-4141(200201)32:1<231::Aid-immu231>3.0.Co;2-8 · DOI
  108. Gillitzer, 1993, MCP-1 mRNA Expression in Basal Keratinocytes of Psoriatic Lesions, J Invest Dermatol, 101, 10.1111/1523-1747.ep12363613 · DOI
  109. Wang, 2008, A Functional Promoter Polymorphism in Monocyte Chemoattractant Protein-1 Is Associated With Psoriasis, Int J Immunogenet, 35, 10.1111/j.1744-313X.2007.00734.x · DOI
  110. Donn, 2004, Macrophage Migration Inhibitory Factor Gene Polymorphism Is Associated With Psoriasis, J Invest Dermatol, 123, 10.1111/j.0022-202X.2004.23314.x · DOI
  111. Hernández-Bello, 2021, Macrophage Migration Inhibitory Factor Gene Polymorphisms (SNP -173 G>C and STR-794 CATT5-8) Confer Risk of Plaque Psoriasis: A Case-Control Study, J Clin Lab Anal, 35, 10.1002/jcla.23999 · DOI
  112. Chhabra, 2021, Single-Nucleotide Polymorphism and Haplotype Analysis of Macrophage Migration Inhibitory Factor Gene and Its Correlation With Serum Macrophage Migration Inhibitory Factor Levels in North Indian Psoriatic Patients With Moderate Disease Severity: A Cross-Sectional Study, Indian J Dermatol Venereol Leprol, 10.25259/ijdvl_988_19 · DOI
  113. Bezdek, 2018, Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis, Front Immunol, 9, 10.3389/fimmu.2018.02262 · DOI
  114. Shimizu, 2001, High Macrophage Migration Inhibitory Factor (MIF) Serum Levels Associated With Extended Psoriasis, J Invest Dermatol, 116, 10.1046/j.0022-202x.2001.01366.x · DOI
  115. Shimizu, 2002, Histochemical Analysis of Macrophage Migration Inhibitory Factor in Psoriasis Vulgaris, Histochem Cell Biol, 118, 10.1007/s00418-002-0435-x · DOI
  116. Abji, 2020, Proteinase-Mediated Macrophage Signaling in Psoriatic Arthritis, Front Immunol, 11, 10.3389/fimmu.2020.629726 · DOI
  117. Fuentelsaz-Romero, 2020, GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis, Front Immunol, 11, 10.3389/fimmu.2020.613975 · DOI
  118. Tang, 2016, The Prolactin Receptor is Expressed in Rheumatoid Arthritis and Psoriatic Arthritis Synovial Tissue and Contributes to Macrophage Activation, Rheumatol (Oxford), 55, 10.1093/rheumatology/kew316 · DOI
  119. Tang, 2017, Rheumatoid Arthritis and Psoriatic Arthritis Synovial Fluids Stimulate Prolactin Production by Macrophages, J Leukoc Biol, 102, 897, 10.1189/jlb.2A0317-115RR · DOI
  120. Huang, 2010, Targeting the ANGPT-TIE2 Pathway in Malignancy, Nat Rev Cancer, 10, 10.1038/nrc2894 · DOI
  121. Scott, 2002, Constitutive Expression of Angiopoietin-1 and -2 and Modulation of Their Expression by Inflammatory Cytokines in Rheumatoid Arthritis Synovial Fibroblasts, J Rheumatol, 29
  122. Shahrara, 2002, Differential Expression of the Angiogenic Tie Receptor Family in Arthritic and Normal Synovial Tissue, Arthritis Res, 4, 10.1186/ar407 · DOI
  123. Fearon, 2003, Angiopoietins, Growth Factors, and Vascular Morphology in Early Arthritis, J Rheumatol, 30
  124. Krausz, 2012, Angiopoietin-2 Promotes Inflammatory Activation of Human Macrophages and Is Essential for Murine Experimental Arthritis, Ann Rheum Dis, 71, 10.1136/annrheumdis-2011-200718 · DOI
  125. Kabala, 2020, Promotion of Macrophage Activation by Tie2 in the Context of the Inflamed Synovia of Rheumatoid Arthritis and Psoriatic Arthritis Patients, Rheumatol (Oxford), 59, 10.1093/rheumatology/kez315 · DOI

Cited by

Sorted by citations

Metadata

Authors
Kamata, M., & Tada, Y.
Venue
Frontiers in Immunology
Publisher
Frontiers Media SA
Published
2022-06-28
Volume
13
ISSN
1664-3224
DOI
10.3389/fimmu.2022.941071
PMC
PMC9274091
Cited by
204
References
9
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review